LSD1-mediated repression of GFI1 super-enhancer plays an essential role in erythroleukemia

作者: Goichi Tatsumi , Masahiro Kawahara , Ryusuke Yamamoto , Masakatsu Hishizawa , Katsuyuki Kito

DOI: 10.1038/S41375-019-0614-6

关键词: GATA1Psychological repressionMyeloid leukemiaCell biologyMyeloidBiologyEnhancerCEBPASuper-enhancerTranscription factor

摘要: Super-enhancers (SEs) consist of enhancer clusters with abundant binding transcription factors (TFs) and cofactors. LSD1 is a histone modifier that eliminates SE activity. However, whether suppression by associated leukemogenesis remains unknown. In erythro-megakaryocyte lineage leukemia cells, activation the GFI1 (GFI1-SE) related to induction myeloid differentiation inhibitors NCD38 NCD25 their antileukemia effect. Although functional TF-motifs were concentrated in an evolutionally conserved area, barely induced additional TF recruitment. Instead, cofactors including LSD1, CoREST, HDAC1, HDAC2 evicted from GFI1-SE. Deletion GFI1-SE impaired erythroleukemia cells. Gene set enrichment analysis revealed deletion NCD38-induced programs granulocyte CEBPA network, but restored NCD38-suppressed erythroid development, GATA1 targets, acute (AML) FAB subtype M6 AML myelodysplastic syndrome-related chromosomal abnormalities. Ontologies genes whose expression changes canceled due showed neutropenia signatures. Collectively, our data suggest sustainable repression essential for sustenance

参考文章(60)
Kornel Labun, Tessa G. Montague, James A. Gagnon, Summer B. Thyme, Eivind Valen, CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering Nucleic Acids Research. ,vol. 44, ,(2016) , 10.1093/NAR/GKW398
Beatriz Aranda-Orgilles, Ricardo Saldaña-Meyer, Eric Wang, Eirini Trompouki, Anne Fassl, Stephanie Lau, Jasper Mullenders, Pedro P. Rocha, Ramya Raviram, María Guillamot, María Sánchez-Díaz, Kun Wang, Clarisse Kayembe, Nan Zhang, Leonela Amoasii, Avik Choudhuri, Jane A. Skok, Markus Schober, Danny Reinberg, Piotr Sicinski, Heinrich Schrewe, Aristotelis Tsirigos, Leonard I. Zon, Iannis Aifantis, MED12 Regulates HSC-Specific Enhancers Independently of Mediator Kinase Activity to Control Hematopoiesis Cell Stem Cell. ,vol. 19, pp. 784- 799 ,(2016) , 10.1016/J.STEM.2016.08.004
Yoshinori Ishikawa, Kanae Gamo, Masato Yabuki, Shinji Takagi, Kosei Toyoshima, Kazuhide Nakayama, Akiko Nakayama, Megumi Morimoto, Hitoshi Miyashita, Ryo Dairiki, Yukiko Hikichi, Naoki Tomita, Daisuke Tomita, Shinichi Imamura, Misa Iwatani, Yusuke Kamada, Satoru Matsumoto, Ryujiro Hara, Toshiyuki Nomura, Ken Tsuchida, Kazuhide Nakamura, A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells. Molecular Cancer Therapeutics. ,vol. 16, pp. 273- 284 ,(2017) , 10.1158/1535-7163.MCT-16-0471
N Sugino, M Kawahara, G Tatsumi, A Kanai, H Matsui, R Yamamoto, Y Nagai, S Fujii, Y Shimazu, M Hishizawa, T Inaba, A Andoh, T Suzuki, A Takaori-Kondo, A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers. Leukemia. ,vol. 31, pp. 2303- 2314 ,(2017) , 10.1038/LEU.2017.59
Monica Cusan, Sheng F. Cai, Helai P. Mohammad, Andrei Krivtsov, Alan Chramiec, Evangelia Loizou, Matthew D. Witkin, Kimberly N. Smitheman, Daniel G. Tenen, Min Ye, Britta Will, Ulrich Steidl, Ryan G. Kruger, Ross L. Levine, Hugh Y. Rienhoff, Richard P. Koche, Scott A. Armstrong, LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML. Blood. ,vol. 131, pp. 1730- 1742 ,(2018) , 10.1182/BLOOD-2017-09-807024
Tamara Maes, Cristina Mascaró, Iñigo Tirapu, Angels Estiarte, Filippo Ciceri, Serena Lunardi, Nathalie Guibourt, Alvaro Perdones, Michele M.P. Lufino, Tim C.P. Somervaille, Dan H. Wiseman, Cihangir Duy, Ari Melnick, Christophe Willekens, Alberto Ortega, Marc Martinell, Nuria Valls, Guido Kurz, Matthew Fyfe, Julio Cesar Castro-Palomino, Carlos Buesa, ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia Cancer Cell. ,vol. 33, pp. 495- ,(2018) , 10.1016/J.CCELL.2018.02.002
Ryusuke Yamamoto, Masahiro Kawahara, Shinji Ito, Junko Satoh, Goichi Tatsumi, Masakatsu Hishizawa, Takayoshi Suzuki, Akira Andoh, Selective dissociation between LSD1 and GFI1B by a LSD1 inhibitor NCD38 induces the activation of ERG super-enhancer in erythroleukemia cells. Oncotarget. ,vol. 9, pp. 21007- 21021 ,(2018) , 10.18632/ONCOTARGET.24774
Daniela Magliulo, Rosa Bernardi, Samantha Messina, Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia. Frontiers in Oncology. ,vol. 8, pp. 255- ,(2018) , 10.3389/FONC.2018.00255
Cihangir Duy, Matt Teater, Francine E. Garrett-Bakelman, Tak C. Lee, Cem Meydan, Jacob L. Glass, Meng Li, Johannes C. Hellmuth, Helai P. Mohammad, Kimberly N. Smitheman, Alan H. Shih, Omar Abdel-Wahab, Martin S. Tallman, Monica L. Guzman, David Muench, H. Leighton Grimes, Gail J. Roboz, Ryan G. Kruger, Caretha L. Creasy, Elisabeth M. Paietta, Ross L. Levine, Martin Carroll, Ari M. Melnick, Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML. Cancer Discovery. ,vol. 9, pp. 872- 889 ,(2019) , 10.1158/2159-8290.CD-19-0106
A. F. Da Cunha, A. F. Brugnerotto, A. S. Duarte, C. Lanaro, G. G. L. Costa, S. T. O. Saad, F. F. Costa, Global gene expression reveals a set of new genes involved in the modification of cells during erythroid differentiation web science. ,vol. 43, pp. 297- 309 ,(2010) , 10.1111/J.1365-2184.2010.00679.X